Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enochian Biosciences Inc (ENOB)
NASDAQ:ENOB
RESEARCH TOOLSreports
Holding ENOB?
Track your performance easily
ENOB Stock Chart & Stats
Day’s Range$0.7 - $0.75
52-Week Range― - ―
Previous Close$0.7
Volume88.38K
Average Volume (3M)N/A
Market Cap
$49.54M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
May 15, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding58,283,591
10 Day Avg. Volume101,396
30 Day Avg. Volume461,292
Standard Deviation0.22
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.73
Price to Sales (P/S)765.31
Price to Cash Flow (P/CF)-3.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Enochian Biosciences News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ENOB FAQ
What was Enochian Biosciences Inc’s price range in the past 12 months?
Currently, no data Available
What is Enochian Biosciences Inc’s market cap?
Currently, no data Available
When is Enochian Biosciences Inc’s upcoming earnings report date?
Enochian Biosciences Inc’s upcoming earnings report date is May 15, 2023 which is 548 days ago.
How were Enochian Biosciences Inc’s earnings last quarter?
Enochian Biosciences Inc released its earnings results on Feb 13, 2023. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.08.
Is Enochian Biosciences Inc overvalued?
According to Wall Street analysts Enochian Biosciences Inc’s price is currently Overvalued.
Does Enochian Biosciences Inc pay dividends?
Enochian Biosciences Inc does not currently pay dividends.
What is Enochian Biosciences Inc’s EPS estimate?
Enochian Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enochian Biosciences Inc have?
Currently, no data Available
What happened to Enochian Biosciences Inc’s price movement after its last earnings report?
Enochian Biosciences Inc reported an EPS of -$0.08 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.448%.
Which hedge fund is a major shareholder of Enochian Biosciences Inc?
Currently, no hedge funds are holding shares in ENOB
---
Enochian Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Enochian Biosciences Inc
Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Los Angeles, CA.
---
Technical Analysis
---